Sector consensus Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
15:05:08 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,631.90 INR | -3.11% |
|
-8.21% | +43.19% |
| 09-25 | Caplin Point Laboratories Limited Approves Appointment of D Muralidharan as Whole Time Director | CI |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,328.83 | +15.57% | 29 | ||||||
| 279.27 | +7.97% | 22 | ||||||
| 278.86 | +7.28% | 28 | ||||||
| 155.76 | +8.31% | 25 | ||||||
| 375.34 | +7.55% | 19 | ||||||
| 151.76 | +6.77% | 22 | ||||||
| 210.47 | +32.41% | 23 | ||||||
| 390.94 | -4.01% | 29 | ||||||
| 158.65 | +7.56% | 26 | ||||||
| 307.56 | +23.02% | 23 | ||||||
| 28.91 | +2.82% | 26 | ||||||
| 571.39 | +12.76% | 28 | ||||||
| 66.71 | +8.54% | 24 | ||||||
| 979.36 | +8.96% | 14 | ||||||
| 94.06 | +28.67% | 24 | ||||||
| 21.75 | +21.16% | 21 | ||||||
| 120.67 | -36.13% | 18 | ||||||
| 853.19 | +16.11% | 26 | ||||||
| 154.21 | +14.7% | 14 | ||||||
| Average | 343.56 | +10.00% | 23 | ||||||
| Weighted average by Cap. | 496.04 | +10.86% | 25 |
Select your edition
All financial news and data tailored to specific country editions
